Floatz logo

Vinorelbine

Hormone Receptor Positive

Spanish Breast Cancer Research GroupPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Hormone Receptor Positive cohort.

Asset / SponsorPhaseRating
Neratinib
Spanish Breast Cancer Research Group
Phase 2CCC
Colesevelam
Spanish Breast Cancer Research Group
Phase 2CCC
Loperamide
Spanish Breast Cancer Research Group
Phase 2CCC
Trastuzumab Emtansine
Spanish Breast Cancer Research Group
Phase 2CCC
np137
Centre Leon Berard
Phase 1CC

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →